[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] AstraZeneca launched new 'Patient Assistance Program' (6)


  • From: "BONFACE FUNDAFUNDA" <bcfunda@hotmail.com>
  • Date: Mon, 13 Nov 2006 13:46:29 +0000

E-DRUG: AstraZeneca launched new 'Patient Assistance Program' (6)
----------------------------------------------------------

Dear all,

This is exactly what many of us thought would be the next development
after direct-to-customer sale of pharma drugs (specifically over the
internet): Companies providing an expanded service direct to patients,
by- passing the legal entities mandated to provide healthcare
services. So these companies want to offer this 'patient assistance
program'. I cannot see them being responsible and liable for any
untowards effects / events that might occur as a consequence of their
'assistance', whereas a local hospital and even a Ministry of health
might assume that liability.

Other colleagues have pointed out that there's plenty of commercial
incentive for such assistance, including so- called social
responsibility. But I think this sort of idea is stretching social
responsibility rather too far. Industry should be looking at other
ways such as ensuring national authorities are empowered to provide
full and effective services to the public (who, afterall, are their
potential customers), rather than promote activities that would in
fact conflict with the responsibilities national health systems.

Regards,

Bonnie
Bonface Fundafunda PhD, MBA, B.Pharm(Hon)
Hartmannsvej 16,
Kgs.Lyngby
2800 Denmark
bcfunda@hotmail.com